A cute ischemic stroke caused by large intracranial arterial occlusion is associated with high morbidity and mortality.
cute ischemic stroke caused by large intracranial arterial occlusion is associated with high morbidity and mortality. 1 Arterial recanalization and tissue reperfusion, either by intravenous thrombolysis or endovascular therapy, are the most effective strategy in improving patient outcome. Intravenous tissue-type plasminogen activator (tPA) has proven to be effective in improving clinical outcomes in patients ≤4.5 hours of symptoms onset. 2, 3 However, recanalization in the presence of proximal large-vessel occlusion is limited, estimated to be only 5% to 14% for internal carotid artery and 30% to 50% for M1 segment. [4] [5] [6] [7] Endovascular stroke therapy (EST), including the use of mechanical thrombectomy and intra-arterial thrombolytic agents, has emerged as an option for patients who fail to recanalize with or ineligible for intravenous tPA. Although EST has shown effective recanalization rates and a relatively good safety profile, [8] [9] [10] [11] [12] most clinical trials have not shown that this strategy improves clinical outcomes. 7, 13 This could be explained by either lack of effectiveness or alternatively, by suboptimal patient selection not sufficiently based on the viability of brain tissue.
Several neuroimaging techniques, including MRI of the brain, MR perfusion, and computed tomography (CT) perfusion, have been studied to improve patient selection for acute EST by identifying a small core infarct with a large penumbral territory that can be salvaged with reperfusion therapy.
Stroke
February 2014 pretreatment MRI had unfavorable outcome, despite successful recanalization.
In patients considered for EST, we hypothesize that addition of pretreatment MRI to determine the core infarct volume before intervention could improve patient selection. Furthermore, we want to ascertain whether any additional delay to initiation of EST resulted from incorporating the pretreatment MRI into our acute endovascular stroke treatment algorithm.
Methods

Subjects
Using our acute stroke endovascular database, between January 2008 and August 2012, we retrospectively identified patients aged ≥18 years who presented to our emergency department or transferred from other hospitals with acute ischemic stroke ≤8 hours since last known well were considered for EST. All patients received acute stroke standard of care treatment, including intravenous tPA if eligible. The institutional review board approved this study.
Baseline clinical characteristics and treatment parameters were systematically collected, including demographic data, stroke risk factors, presentation in our emergency department versus transferred from other hospitals, initial National Institutes of Health Stroke Scale (NIHSS), time of last known well, pretreatment imaging, and endovascular treatment modality (use of intra-arterial thrombolysis with glycoprotein IIb/IIa inhibitors and tPA, intra-and extracranial angioplasty and stenting, and mechanical thrombectomy with 
Prehyperacute MRI Protocol
Patients in the prehyperacute MRI period were presented from January 1, 2008, to April 29, 2010. They were selected for EST on the basis of clinical examination with initial NIHSS≥8, noncontrast CT of the head that did not show an acute infarct in >1/3 of the vessel territory, and CT angiography (CTA) showing a corresponding large cerebral arterial occlusion (cervical internal carotid artery, intracranial internal carotid artery, M1, M2/M3, and vertebrobasilar; see online-only Data Supplement for imaging parameters).
Hyperacute MRI Protocol
Patients in the hyperacute MRI period were presented from April 30, 2010, to August 31, 2012. They were selected for endovascular therapy on the basis of previously stated CT/CTA criteria and the result of the pretreatment brain MRI. Patients with a clinically large stroke were taken directly for hyperacute MRI after CTA revealed the presence of a large-vessel occlusion. Those with a contraindication to CTA, such as an increased creatinine or allergy to iodine contrast, or those with nondiagnostic CTA whose clinical examination was consistent with a large-vessel occlusion were taken for hyperacute MRI, and in these instances an MRA of the head and neck were obtained. To minimize time to endovascular therapy, as soon as a clinical examination with baseline (NIHSS≥8) and concomitantly large-vessel occlusion was found on CTA, the endovascular team was activated (Figure 1 ). On the basis of these results of MRI, we found that those thought to have either clinical-DWI mismatch (clinical deficits out of proportion to DWI lesion, approximately <70-mL volume core infarct by visual inspection) or DWI-perfusion weighted imaging mismatch (by visual inspection of perfusion maps) were immediately taken for EST.
Interventional Procedure
The individual endovascular interventionalist determined the method and device(s) used for each case. Intra-arterial tPA and glycoprotein IIb/IIIa inhibitors and their doses were recorded when used. General endotracheal anesthesia or monitored local sedation was performed as clinically indicated. Location of occlusion, recanalization was measured using thrombolyisis in cerebral infarction recanalization grading system, 19 and the time of recanalization were recorded (M.S.H., F.H., G.T.).
Postprocedure Follow-up
Post-treatment noncontrast CT was done in all patients and analyzed for hemorrhagic transformation on the basis of The European Cooperative Acute Stroke Study (ECASS) criteria. 20 If patients were stable, we repeated the MRI, including DWI imaging, at 48 to 72 hours. Modified Rankin scale (mRS) was determined at 30 days at an outpatient stroke clinic follow-up, by telephone call by stroke nurse or by review of medical records by a stroke fellow if sufficient documentation was present. All individuals were mRS certified.
Statistical Analysis
Univariate analysis was performed using cross table for categorical variables and Student t test, ANOVA test, and Wilcoxon rank-sum test were used for continuous variables. The primary comparison groups analyzed by univariate analysis were the prehyperacute MRI and hyperacute MRI period groups. The primary outcome-dependent variable was defined as a 30-day mRS≤2. Multivariate logistical regression analysis was performed to calculate the adjusted odds ratios (ORs) of good outcome and mortality by using the hyperacute MRI period after adjusting for common stroke risk factor and demographic variables (age, sex, intravenous tPA treatment, time to evaluation). We used the SPSS program (version 20; IBM SPSS Statistics, Armonk, NY) to analyze our data. All variables with a P=0.1 were entered in the logistic regression model. A P value <0.05 was considered significant.
Results
All Patients
Two-hundred sixty-seven patients (88, 33.0% in prehyperacute MRI period and 179, 67.0% in hyperacute MRI period) were included in our study analysis. Baseline clinical characteristic is summarized in Table 1 . There were no significant differences in stroke severity measured by median NIHSS score and the retrospectively obtained median Alberta Stroke Program Early CT Score (ASPECTS). There were more cases 
12).
In the prehyperacute MRI period, all but 3 (3.4%) of the 88 patients received EST. One (1.1%) did not receive therapy because of T-occlusion and the risk of procedure was deemed greater than potential benefit; and 2 (2.3%) had anatomy that precluded access to the target vessel. By contrast, in the hyperacute MRI period, only about half of the patients who were thought to be candidates based on CT/CTA underwent endovascular intervention after hyperacute MRI (85 of 88, 96.6% versus 92 of 179, 51.7%; P<0.05). The most frequent reasons for exclusion from EST in the hyperacute MRI period were infarction on DWI that matched the clinical presentation, and large infarcted volume on DWI that was not apparent on CT (online-only Data Supplement).
Despite decreasing the rate of endovascular therapy performed for acute stroke in the hyperacute MRI period, a greater proportion had more favorable outcome (Figure 2A ) based on 30-day mRS≤2 (6 of 66, 9.1% versus 33 of 140, 23.6%; P=0.01) and decreased 30-day mortality (32 of 66, 48.5% versus 35 of 140, 25%; P<0.001). On multiple logistic regression analysis, age, baseline NIHSS, and pretreatment MRI were significantly associated with good 30-day clinical outcome (mRS≤2). Patients selected in the hyperacute MRI period were more likely to achieve a favorable outcome (mRS≤2) at 30 days than those selected in the prehyperacute MRI period (adjusted OR for common risk factor, 3.6; 95% confidence interval, 1.3-10.2; P=0.014; Table 2 ). In addition, the adjusted OR of 30-day mortality was decreased in the hyperacute MRI period (adjusted OR for common risk factors, 0.28; 95% confidence interval, 0.14-0.5; P<0.001).
Interventional Cases Only
One-hundred seventy-seven interventional cases were included: 92 during the hyperacute MRI period and 85 during the posthyperacute MRI period. Patients in the prehyperacute MRI period were treated more frequently with intra-arterial tPA or glycoprotein IIb/IIIa inhibitors and multimodal therapy (with intra-arterial lytic agents and mechanical thrombectomy) was also more frequent (Table 1 ). In the prehyperacute MRI period, the most common device used was the MERCI retrieval device (Concentric Medical); in the hyperacute MRI period, the most frequent device used was the Penumbra Aspiration System (Penumbra; Table 1 ). Despite differences in procedure, recanalization rate was similar between the 2 groups (thrombolyisis in cerebral infarction 2b-3, 42 of 85, 49.4% versus 51 of 92, 55.4%; P=0.4). However, higher rate of favorable clinical outcome was achieved in the hyperacute MRI period (6 of 63, 9.5% versus 17 of 71, 23.9%; P=0.03; Figure 2B ).
Mean times from last known well to CTA (220 versus 226 minutes; P=0.76), first run (407 versus 390 minutes; P=0.81) and recanalization (483 versus 463 minutes; P=0.85) were similar in both groups. Despite obtaining pretreatment MRI, the time to EST was not significantly delayed (Table 1 ; Figure 1 ).
On multivariate logistic regression analysis, only pretreatment NIHSS and MRI were associated with outcome. Patients who had endovascular therapy in the hyperacute MRI period were more likely to have favorable clinical outcome (adjusted OR, 3.4; 95% confidence interval, 1.1-10.6; P=0.03; Table 2 ). The 30-day mortality also decreased in the hyperacute MRI period (30 of 63, 47.6% versus 14 of 71, 19.7%; P<0.001) with adjusted OR 0.16 and 95% confidence interval 0.06 to 0.37, P<0.001.
Discussion
The addition of pretreatment MRI to CT-based imaging for patient selection reduced the number of interventions by ≈50% and may aid in selection of patient for EST. We observed that patients were 3× more likely to be independent in the hyperacute MRI period at 30 days, both in the overall group and among those taken to endovascular therapy. Furthermore, the 30-day mortality rate was significantly reduced in the hyperacute MRI period. This was also accomplished without significant delay in the time to the start of intervention. It is interesting that the overall group, including both those who received intervention and those who did not, had improved outcomes. This was a retrospective review, and it is possible that other, unaccounted factors may also be contributing to the improved outcomes over time. However, as shown in Table 1 , the baseline factors that are typically considered to be the most influential of outcome were generally balanced between the 2 groups, and when these variables were adjusted for in the multivariate analysis, the use of MRI protocol remained significant. It is possible that not exposing patients with large infarctions to endovascular therapy (including exposure to anesthesia, sedation, and vessel manipulation) may also be beneficial and lead to better outcome. Our experience suggests that MRI may aid in patient selection for endovascular therapy.
It is important to note that our study did not address the efficacy of EST when compared with standard medical therapy. Recent randomized controlled trials, Interventional Management of Stroke III, 7 and Synthesis-Expansion 13 did not show improved efficacy of endovascular therapy in conjunction with intravenous tPA or endovascular therapy alone when compared with intravenous tPA for treatment of acute ischemic stroke. However, both trials included a relatively unselected population of patients. In Interventional Management of Stroke III, 7 patients all presented within 3 hours of symptom onset and only required a NIHSS≥10 to be included. Only 47% of patients in the study had a baseline CTA performed, and large-vessel occlusion was not required for eligibility. In the secondary analyses, there was a suggestion that patients who were treated with intravenous tPA≤ 2 hours from symptom onset or those who had time of groin puncture ≤90 minutes after the initiation of intravenous tPA had a better trend toward improved outcome with combined intravenous plus intra-arterial stroke therapy. 7 Certainly, time is an important factor and in those presenting early after symptom onset many are advocating reducing time to treatment further. However, it is also important to note that these were trends and not statistically significant.
In our patient population, the majority were transferred from other centers with a mean time of arrival at 207 minutes in the prehyperacute MRI period versus 262 minutes in the posthyperacute MRI period (P=0.04). In this latter time window, the chance of good outcome from unselected populations has been shown to be low, 21 and patient selection with imaging may be more important. In addition, it has been shown by Sun et al 22 that patients transferred from another facility introduces significant delay in patient treatment and this is associated with decreased chances of good clinical outcome. This presents an opportunity for process improvement to decrease time delays by developing an acute stroke screening and transfer protocols for patients who may be a candidate for EST.
It is critical when performing EST to identify patients without a large infarct volume before treatment. In our study, patients were disqualified from endovascular therapy because of large core infarction detected by DWI that was not seen on noncontrast CT or matched clinical deficits and DWI lesion.
Although CT ASPECTS has been retrospectively found to be predictive of outcome, [23] [24] [25] CT remains a test with high specificity but low sensitivity in acute stroke. Weir et al 26 demonstrated that low ASPECTS was predictive of poor outcome, but individual prediction in good scans (ASPECTS, 6-10) was still poor. Because of its low sensitivity, it is likely that CT-based approach may not reliably identify those who have substantial volume of irreversibly damaged tissue, and thus patients without a salvageable target will be exposed to therapy. DWI is more sensitive for acute ischemia, with sensitivity rates from 90% to 100%. 16, 27 Recent evidence also suggests that the size of the DWI core lesion is predictive of outcome, with those having >70-mL lesions not achieving good clinical outcome. 15 There are several limitations to this study. This is a retrospective single-center, pre-/postanalysis. There might be the unaccounted factors and changes in practice over time, such as different interventionalists, more effective endovascular treatment devices/strategies, and expansion of our neurointensive care units, which may have contributed to better outcome during the posthyperacute period. There were also differences in vessel occlusion location and a trend toward lower intravenous tPA use in the pre-MRI era. Although the MRI protocol was significant in multivariate analysis, these other factors have been established to affect outcome, thus the presence of these findings should result in caution against over interpretation of the results.
As we try to advance acute stroke treatment, selection of patients for endovascular treatment will be important. EST applied to unselected population has not proven successful, and newer approaches are needed. Our use of the hyperacute MRI in our patient population with acute large-vessel occlusion seems to have decreased its use and may aid in patient selection. These results are intriguing and we advocate for further study of MRI-based selection for EST. 
